Experimental work demonstrates antiviral activity of pyrazole nucleosides against Zika virus and SARS-CoV-2.
Pyrazole ribonucleoside analogues were prepared via a linear approach starting with the reaction of D-ribosylhydrazine with 1,3-dicarbonyl or acrylonitrile derivatives, thereby avoiding the regio- and stereoselectivity challenges typically encountered in N-glycosylation reactions. Three series of pyrazole nucleoside analogues, as along with selected corresponding pronucleotides, were prepared and their antiviral activity against Zika virus and Sars-Cov-2 is reported.
No takes yet. Share an insight, caveat, or question.
Guillou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: